Pharmaceutical

Gilead reports 8.45% dip in net income for Q2 2023

Gilead Sciences has posted net income of $1.03bn in Q2 of 2023 compared with $1....

Bangladesh and the dengue vaccine question

Amid one of the worst dengue fever outbreaks in decades, Bangladesh has recorded...

BlueRock and bit.bio link to develop regulatory T cell-...

BlueRock Therapeutics signed an agreement with bit.bio to discover and manufactu...

US FDA approves Merck’s Ebola vaccine for under-18s

The US FDA has granted approval for an expanded indication of Merck’s Ebola vacc...

Tweets of the week: Purdue bankruptcy, HIV prevention a...

This week, people are tweeting about Purdue's ongoing bankruptcy case, pandemic ...

Opinion: Former Sen. Max Baucus: Breakthrough Alzheimer...

Former Sen. Max Baucus: We must continue to forge a path to swift, affordable co...

Opinion: Without a plan to fight superbugs, the Cancer ...

Antimicrobial resistance is a threat to everyone. But cancer patients are partic...

STAT+: Uninsured rate hits ‘record low’ — right before ...

New CDC survey data show 7.7% of Americans had no health insurance as of this pa...

STAT+: Vertex non-opioid therapy reduced pain in mid-st...

A pair of Vertex clinical trials showed an experimental non-opioid drug reduced ...

STAT+: With new acquisitions, Humana and CVS hope to tu...

Humana and CVS Health are working to funnel their health plan members into their...

ProMED, an early warning system on disease outbreaks, a...

The early warning disease network that alerted the world to the original SARS ou...

‘Shocking’ heat waves persist through August as federal...

An already record-setting summer heat wave will continue through August and will...

CDC recommends RSV monoclonal antibody for infants, hig...

A panel of advisers to the CDC unanimously voted Thursday to recommend wide use ...

Stress in childhood linked to physical and cognitive pr...

Adults ages 50-97 who had experienced violence as children were 80% more likely ...

Listen: Biotech layoffs, eye drug drama, & gene therapy...

Can biotech startups survive a downturn? Is Covid-19 a good business? And when d...